FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.
Fortress Biotech, Inc. (NASDAQ:FBIO), a biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has extended the target action date for the New Drug Application ...
The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...
Smithsonian Magazine on MSN3d
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab RatsAfter decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food ...
FDA sets August 31, 2025, as the action date for Eisai and ... patients with Mild Cognitive Impairment or mild dementia ...
The U.S. Food and Drug Administration is reviewing reports that more than 1,000 dogs died in an 18-month span after taking an arthritis drug called Librela.
Irish neurotech company CergenX has received the Breakthrough Device Designation from the US FDA while being accepted into the TAP program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback